Background Fungating wounds arise from primary, secondary or recurrent malignant
disease and are associated with advanced cancer. A small proportion of patients may …

The aim of this paper was to provide a literature synthesis on current wound care practices
for the management of chronic wounds in palliative care and end‐of‐life patients, focusing …

Objective: To investigate the evidence exploring the experiences of patients with fungating
wounds and associated quality of life, and to subsequently provide recommendations to how …

Background Malignant wounds are a devastating complication of cancer. They usually
develop in the last six months of life, in the breast, chest wall or head and neck regions. They …

OBJECTIVE: To formulate a patient-rated assessment tool that facilitates the measurement
of pain and polysymptom distress directly related to all classes of wounds. DESIGN: A …

Woundcare Research for Appropriate Products (WRAP) is a novel collaboration WRAP
between industry and clinicians, funded by the Engineering and Physical Research …

This article discusses the Government's drive to promote health professional and patient
partnership working within healthcare, with a focus on enhancing wellbeing and how this …

Fungating malignant wounds are caused by tumor infiltration of the skin. Unless amenable
to anti-cancer treatments, the infiltration extends, the wounds advance, and the management …

Living with a malodorous, fungating wound can cause psychological and physical distress.
This review explores whether nurses consider the psychological impact of dressing such …

Las heridas neoplásicas están relacionadas con el tumor y requieren un abordaje especial
y más cuidadoso por los diferentes factores asociados con el cáncer. Se pueden encontrar …